Suboxone Tooth Decay Lawsuit

November 6, 2024

Suboxone Tooth Decay Litigation Update: Judge Orders Comprehensive Census for Trial PreparationThe U.S. District Judge overseeing the Suboxone tooth decay lawsuits has mandated a complete census of all current claims.

This census will give an overview of the cases and pinpoint representative claims that may proceed to early bellwether trials, helping the parties assess how juries might respond.

Indivior faces over 11,000 lawsuits alleging that Suboxone’s sublingual film led to severe dental issues, such as tooth decay and enamel erosion, which plaintiffs claim were not sufficiently disclosed.

Despite Suboxone’s long presence on the market, warnings about dental risks were not added until June 2022, which plaintiffs contend contributed to preventable injuries.

These lawsuits have been consolidated in a multidistrict litigation (MDL) overseen by U.S. District Judge Philip Calabrese, who is coordinating discovery and preparing for bellwether trials to offer insights into likely jury responses to shared evidence.

After an October 2024 conference, Judge Calabrese issued a case management order specifying the census protocols.

The census will encompass both individual lawsuits and bundled Schedule A cases submitted earlier this year, excluding cases filed after October 7, 2024.

This census and related proceedings are essential steps in advancing the litigation and assessing fair compensation for Suboxone users affected by dental damage.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

November 1, 2024

The Suboxone Tooth Decay Lawsuit involves claims that the opioid addiction treatment drug Suboxone has caused serious dental issues, including advanced tooth decay, erosion, and even tooth loss.

Plaintiffs argue that the manufacturer, Indivior, did not sufficiently warn users of the significant risk of dental damage associated with Suboxone use.

In October, there were 674 cases filed regarding Suboxone-related tooth decay claims. By November, this number had risen slightly to 678, with 4 additional cases.

This gradual increase indicates that awareness of potential dental complications from long-term Suboxone use continues to grow.

Suboxone’s effects on dental health can result in painful and costly dental treatments, impacting the quality of life for individuals using the medication for opioid addiction treatment.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

The Suboxone Tooth Decay Lawsuit highlights claims that the drug, prescribed for opioid addiction and opioid use disorder (OUD), causes severe dental damage, including tooth decay, tooth loss, and other oral health issues.

Plaintiffs contend that Suboxone’s manufacturers failed to adequately warn about the drug’s potential to cause serious dental harm.

In September and October, the Judicial Panel on Multidistrict Litigation (JPML) recorded 674 active Suboxone tooth decay lawsuits.

Suboxone users have reported rapid tooth decay and tooth loss, leading to costly dental procedures such as root canals, dentures, or implants.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

The Suboxone Lawsuit is ongoing. 

An Ohio federal judge recently dismissed Indivior PLC and two Reckitt Benckiser entities from the Suboxone MDL, which alleges that Suboxone, an opioid addiction treatment, caused dental decay.

U.S. District Judge J. Philip Calabrese issued the dismissal after the parties involved reached an agreement.

In the case filed by plaintiff Ryan Bennett, the dismissal was with prejudice, meaning it cannot be refiled.

However, for other claims in the MDL, the dismissal was without prejudice, allowing those cases to potentially be brought again.

The litigation centers on allegations that the companies failed to warn consumers about Suboxone’s dissolvable film, which has acidic properties that could damage teeth.

While Indivior and Reckitt Benckiser have been dismissed, the litigation continues against other defendants, including Aquestive Therapeutics Inc.

The MDL, consolidated in February 2024, includes claims from multiple states and follows Indivior’s earlier settlement of antitrust claims over Suboxone in a separate case.

If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to connect with a Suboxone lawyer.

The Suboxone Tooth Decay Lawsuit, involving allegations that Suboxone use has caused serious dental issues, has seen a minor increase in filings.

In August 2024, there were 673 active cases, with the number rising slightly to 674 by September 2024.

Plaintiffs argue that despite following good dental practices, Suboxone users have experienced severe tooth decay, and they claim the manufacturer failed to adequately warn of these potential risks.

If you or a loved one took Suboxone and subsequently suffered severe tooth decay, you may be eligible to take action and file a Suboxone Lawsuit. 

Contact TruLaw for a free consultation. 

Use the chatbot on this page to find out if you qualify to file a Suboxone Lawsuit and to get in touch with a licensed Suboxone lawyer.

The Suboxone Lawsuit involves claims against the drug’s manufacturer regarding a heightened risk of severe tooth decay and other dental injuries.

In July, there were 677 filings in the Suboxone lawsuit, which slightly decreased to 673 by August.

Suboxone, a medication used to treat opioid addiction, has been linked with severe tooth decay, including cavities, tooth loss, and other severe dental problems.

Many individuals have filed lawsuits against Indivior, claiming that the company failed to adequately warn about these dental risks, leading to significant health complications and financial issues for dental treatments.

If you or a loved one took Suboxone and subsequently suffered severe tooth decay, you may be eligible to take action and file a Suboxone Lawsuit. 

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify to file a Suboxone Lawsuit and to get in touch with a licensed Suboxone lawyer.

July 29, 2024

August 16 & 27, 2024: Key Submission Dates

Key dates for the Suboxone Tooth Decay Lawsuit are fast approaching. 

Suboxone Lawsuits are advancing with submission dates in August 2024 and a potential settlement timeline extending into mid-2025.

The litigation is continuing to grow, and lawyers are still accepting new Suboxone claims.

In June 2024, there were 258 Suboxone Lawsuit filings reported by the JPML.

By July 2024, the number of Suboxone Lawsuits had increased to 677.

Key Submission Dates:

• Claim information and party proposals due on August 16 and 27, 2024. These documents are vital for progressing the litigation and may significantly impact the direction of the case.

Settlement Timeline:

• Settlement discussions are expected to extend into mid-2025.
• The earliest potential settlement by June 2025, pending resolution of ongoing issues within the litigation.

Tolling Agreement:

• Progress report due on August 1, 2024.
• The tolling agreement pauses the statute of limitations, allowing time for comprehensive case preparation.

If you or a loved one took Suboxone and subsequently suffered severe tooth decay, you may be eligible to take action and file a Suboxone Lawsuit. 

Contact Keith Law Group for a free consultation. 

Use the chatbot on this page to find out if you qualify to file a Suboxone Lawsuit and to get in touch with a licensed Suboxone lawyer.

The Suboxone Lawsuit is ongoing.

The number of Suboxone lawsuits has increased as more patients come forward to report severe tooth decay and other dental problems associated with the medication, seeking legal support from Suboxone Lawyers.

Suboxone Tooth Decay Lawsuits involve claims of dental injuries resulting from the use of the drug, a medication used for opioid addiction treatment.

The core arguments in the Suboxone Tooth Decay Lawsuits revolve around:

• Failure to Warn: Plaintiffs argue that the manufacturers did not provide adequate warnings about the risk of severe tooth decay associated with Suboxone.

• Negligent Design: Allegations include that the design of Suboxone contributes to an increased risk of dental problems, including tooth decay.

• Lack of Adequate Instructions: Many lawsuits claim that the manufacturers failed to provide proper instructions on how to minimize dental risks while using Suboxone.

In response to the increasing litigation, healthcare professionals recommend the following precautions for those using Suboxone:

• Maintain Oral Hygiene: Follow a strict oral hygiene routine, including brushing and flossing regularly.

• Regular Dental Check-Ups: Schedule frequent dental check-ups to monitor and address any early signs of tooth decay.

• Discuss with Your Doctor: Talk to your healthcare provider about the potential dental risks and ways to mitigate them while using Suboxone.

If you or a loved one has suffered from dental issues due to Suboxone, contact Keith Law Group for a free consultation.

The Suboxone lawsuit is ongoing.

The lawsuit involves claims that the opioid addiction treatment drug Suboxone has caused severe dental issues, including tooth decay, tooth loss, and other dental problems.

This lawsuit seeks to hold the manufacturer accountable for these adverse effects.

In June, there were 258 Suboxone lawsuit filings.

By July, this number increased to 677.

Suboxone can cause significant dental problems, leading to tooth decay and tooth loss.

These issues have prompted more individuals to join the Suboxone lawsuit.

If you or a loved one has been negatively affected by Suboxone, call today for a free consultation. 

You can also use the chatbot on this page for an instant case evaluation

In a recent development, over 9,600 people have added their claims to a collective lawsuit against the manufacturers of Suboxone.

These claims were filed just ahead of a potential cutoff date that could have impacted claim eligibility across several states.

Suboxone, a drug prescribed for opioid addiction treatment, has been linked to serious dental issues such as tooth decay and irreversible damage.

The medication, which contains buprenorphine and naloxone, is commonly used to mitigate opioid withdrawal symptoms.

Initially approved in tablet form in 2002, a sublingual film version was introduced in 2012.

The plaintiffs in the lawsuit argue that this film form was introduced to delay the entry of generic alternatives and failed to provide sufficient warnings about the risks to dental health.

The FDA mandated a warning label for tooth decay on June 17, 2022, following numerous reports of tooth loss.

With the second anniversary of the FDA’s label update approaching, approximately 500 Suboxone lawsuits are currently active in federal courts.

These cases are being managed by U.S. District Judge Philip Calabrese in the Northern District of Ohio, as part of a multidistrict litigation (MDL) that was established in February 2024.

This MDL is designed to streamline discovery and pretrial processes.

Judge Calabrese is anticipated to introduce a bellwether process soon, choosing representative cases for early trials to set precedents for future settlement negotiations.

If you or someone else has suffered from serious tooth decay as a result of using Suboxone, you may be eligible to participate in the Suboxone Lawsuit. 

Contact us for a free consultation, or utilize the chatbot on this page to quickly check your eligibility for the Suboxone Tooth Decay Lawsuit.

The Suboxone Tooth Decay Lawsuit is ongoing. 

U.S. District Judge Philip Calabrese, overseeing the consolidated Suboxone dental decay lawsuits, has formed a Leadership Development Committee (LDC) to enhance case management and legal representation in the Multidistrict Litigation (MDL).

This committee plays a critical role in addressing the broad claims that Suboxone film causes severe dental decay, a side effect not previously disclosed by the drug’s manufacturer.

Suboxone, a drug used for opioid addiction treatment, was introduced in a sublingual film format in 2012.

This formulation of the drug has been linked to severe dental health issues, including enamel erosion, tooth decay, cavities, oral infections, and tooth loss.

After numerous patient complaints, on June 17, 2022, the FDA mandated warnings about the risk of tooth decay to be included on the drug’s labeling.

Plaintiffs argue that earlier warnings could have prevented irreversible dental harm.

Currently, there are approximately 350 product liability lawsuits active in the MDL, and this number is expected to increase as the two-year anniversary of the labeling change approaches—a potential deadline for new claims.

These cases are centralized in the Northern District of Ohio, where they are undergoing coordinated pretrial proceedings under Judge Calabrese.

If you or someone else has suffered from serious tooth decay as a result of using Suboxone, you may be eligible to participate in the Suboxone Lawsuit. 

Contact us for a free consultation, or utilize the chatbot on this page to quickly check your eligibility for the Suboxone Tooth Decay Lawsuit.

The Suboxone Tooth Decay Lawsuit is progressing, and we are open to new clients. The latest data from the Judicial Panel on Multidistrict Litigation (JPML) shows that 258 lawsuits have now been consolidated into the Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation.

These cases assert that Suboxone, especially in its sublingual film or tablet forms, greatly increases the risk of severe tooth decay due to extended contact of the teeth with decay-inducing substances.

This litigation unifies these allegations in a single federal court, addressing the serious dental problems purportedly linked to Suboxone use.

If you or someone else has suffered from serious tooth decay as a result of using Suboxone, you may be eligible to participate in the Suboxone Lawsuit. 

Contact us for a free consultation, or utilize the chatbot on this page to quickly check your eligibility for the Suboxone Tooth Decay Lawsuit.

The Suboxone Tooth Decay Lawsuit is ongoing. 

In the Suboxone lawsuit, plaintiffs are advocating for a tolling agreement to temporarily suspend the statute of limitations, enabling the submission of additional claims for dental injuries allegedly caused by Suboxone.

Since November 2023, the argument has centered on the necessity of such an agreement to effectively manage the litigation.

As of May 2024, there are nearly 500 cases pending in the Suboxone lawsuit.

PLaintiffs caution that without a tolling agreement, the court may face a flood of potential unapproved  claims, which could complicate proceedings and detract from the MDL’s objective of streamlining the process.

Defendants in the Suboxone Tooth Decay lawsuit have consistently opposed the tolling agreement.

This opposition is perceived by plaintiffs as a tactic to increase the litigation burden, potentially deterring the filing of weaker claims and complicating the management of the MDL.

The controversy extends to the Suboxone warning label, updated on June 17, 2022, under FDA guidance to include risks of dental decay and tooth erosion.

The plaintiffs have proposed that the court obligate defendants to respond to each complaint, an effort to pressure defendants into agreeing to the tolling agreement and thus manage their caseload more efficiently, amid concerns of filing claims that may later be dismissed as meritless.

Decisions by the court in the upcoming months could significantly shape the trajectory of the Suboxone Tooth Decay litigation, influencing the strategies of both parties involved in the lawsuit.

The Suboxone Lawsuit remains active.

As per the latest filings with the Judicial Panel on Multidistrict Litigation (JPML), there are currently 205 cases consolidated in the Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation.

This marks a substantial increase, with 161 new cases joining the litigation just in the past month, up from only 44 cases as of April 1st.

The claims in these lawsuits assert that the formulation of Suboxone, especially in its sublingual film or tablet form, results in extended exposure of the teeth to decay-promoting substances.

The Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation consolidates various lawsuits that attribute severe tooth decay to the use of Suboxone into one federal court.

If you or someone close to you has suffered from severe tooth decay as a result of using Suboxone, you may be eligible to file a Suboxone Lawsuit.

Contact us for a free consultation.

You can also determine if you qualify for the Suboxone Tooth Decay Lawsuit instantly by using the chatbot on this page.

As of April 1st, the total number of Suboxone Lawsuits has decreased to 44, down from 51 on March 1st.

These lawsuits have been filed against the manufacturers of Suboxone by individuals who used the drug for opioid addiction treatment and subsequently experienced severe tooth decay and other dental injuries.

In response to these claims, the U.S. Food and Drug Administration (FDA) mandated in 2022 that all Suboxone packaging include warning labels addressing the potential risk of dental problems.

This regulatory action followed reports that many users were not adequately informed of the risks associated with dental health prior to using the medication.

If you or a loved one has been affected by Suboxone, call us today for a free consultation. 

Alternatively, you can use the chatbot on this page for an instant Suboxone Tooth Decay lawsuit evaluation.

The United States District Court for the Northern District of Ohio is currently overseeing the Suboxone Tooth Decay Lawsuit, part of Multidistrict Litigation (MDL) No. 3092.

The court has introduced a direct filing system to facilitate the process for plaintiffs alleging dental injuries due to Suboxone, a medication prescribed for opioid addiction treatment.

This system allows for the consolidation of cases, streamlining the litigation process by eliminating the need for case transfers from various jurisdictions to this centralized court.

Suboxone combines buprenorphine, to alleviate withdrawal symptoms, with naloxone, intended to prevent misuse.

However, forms of Suboxone that dissolve in the mouth have been associated with severe dental issues, including tooth decay, cavities, and loss.

The direct filing mechanism not only expedites the legal proceedings but also simplifies representation by attorneys nationwide, without the need for special permissions or additional fees.

Plaintiffs filing lawsuits are encouraged to propose a trial location tied to personal aspects of their case, such as residency, prescription, or use of Suboxone.

While this does not assure a trial in the suggested locale, it aids in the organization and management of cases within the MDL structure.

This initiative by the Northern District of Ohio aims to enhance access and efficiency for individuals seeking compensation for dental damages allegedly linked to Suboxone.

Individuals experiencing dental problems following Suboxone use are encouraged to seek legal counsel.

The legal battle surrounding Suboxone continues to unfold, with our attorneys actively welcoming additional cases.

As of March 19th, there have been 51 cases incorporated into the Multidistrict Litigation (MDL) addressing tooth decay attributed to Suboxone.

MDLs play a crucial role in efficiently managing multiple lawsuits that share commonalities, particularly in sectors like pharmaceuticals, product defects, and intricate legal issues.

The consolidation of Suboxone cases helps simplify the discovery process, facilitating the exchange of evidence, and expediting the proceedings of individual lawsuits.

The establishment of an MDL specific to Suboxone lawsuits marks an important milestone in the management and potential resolution of these cases.

This approach allows for the amalgamation of resources, fostering a more robust legal strategy supported by in-depth expert analysis and detailed investigative efforts.

Individuals who have experienced dental complications from Suboxone use are provided with an avenue to seek legal remedy and possibly engage in a collective endeavor to secure compensation.

The initiation of this MDL reflects a firm commitment to delivering justice for those who have suffered dental injuries as an unintended outcome of their addiction treatment.

Should you or someone close have encountered severe dental issues as a result of taking Suboxone, you might be eligible for legal recourse. 

Utilizing the chatbot on this page enables you to swiftly determine your eligibility to initiate a Suboxone lawsuit and facilitates connection with a lawyer specialized in Suboxone cases.

The Suboxone Litigation is currently underway, and our attorneys are actively taking on new cases. 

The consolidation of the Suboxone Tooth Decay Lawsuit has been designated to the Northern District of Ohio by the Judicial Panel on Multidistrict Litigation (JPML), which has recently integrated eleven cases into this newly established Multi-District Litigation (MDL).

MDLs are procedural frameworks within the United States designed to handle several civil lawsuits that have overlapping legal issues, facts, or defendants efficiently.

This is especially beneficial when numerous lawsuits across different regions share a specific common issue, like tooth decay allegations linked to Suboxone use, allowing for their consolidation in a single federal district court for the preliminary phase of the trial.

The aim of an MDL is to make the litigation process more efficient by centralizing the discovery phase, reducing redundant work, and achieving consistent rulings on crucial legal questions.

The formation of an MDL provides an avenue for individuals suffering from dental issues due to Suboxone to seek collective redress and compensation through mass tort litigation.

Initiating an MDL for Suboxone Tooth Decay is a significant step forward in securing justice for those affected by dental decay or injuries from this opioid addiction treatment. 

If you or a loved one has suffered from severe tooth decay as a result of Suboxone, you may be eligible to take legal action and initiate a lawsuit.

The chatbot on this page is available to help determine if you are eligible to join the Suboxone Lawsuit and to facilitate contact with a seasoned Suboxone lawyer. 

The Suboxone Tooth Decay Lawsuit is ongoing.

Indivior has agreed to a $385 million settlement to address allegations from U.S. drug wholesalers that the company unlawfully blocked generic competitors of its opioid addiction treatment, Suboxone.

This settlement resolves extended legal battles regarding Suboxone, building on earlier settlements: $102.5 million in June to U.S. states and $30 million in August for a class-action lawsuit by health plans.

A trial set for October 30, involving roughly 70 Suboxone buyers, has now been averted through this settlement.

Indivior had exclusive rights to Suboxone in the U.S. from its approval in 2002 until 2009. The lawsuit focused on accusations that Indivior switched to a film version of Suboxone to illegally extend its market monopoly as generic producers were ready to launch cheaper tablet forms.

Furthermore, in 2020, Indivior settled for $600 million to resolve U.S. government claims of misleading marketing practices concerning Suboxone.

The CDC has linked opioids to over 900,000 overdose deaths in the U.S. since 1999.

Indivior’s CEO, Mark Crossley, remarked that the settlement enhances predictability for the company’s stakeholders, noting the settlement does not admit any liability.

The agreement is pending approval by the United States District Court for the Eastern District of Pennsylvania, with the settlement expected to be paid out in the upcoming month.

Should you or someone you know suffer from severe tooth decay as a result of taking Suboxone, you may have a case for legal action.

The chatbot on this page is ready to help determine if you qualify for a Suboxone Lawsuit and to connect you with an experienced Suboxone lawyer.